Plans for a controversial U.S.-funded hepatitis B vaccine study in Guinea-Bissau have been paused pending further review from national authorities, African officials indicated Thursday.
“There has been no sufficient coordination in order to make a final decision regarding that study,” Quinhin Nantote, Guinea-Bissau’s public health minister, told reporters via an interpreter at a press briefing held by the Africa Centres for Disease Control and Prevention.
